Rekord LOINC: 94578-2
Dostępne tłumaczenie polskie ACTIVE
Tłumaczenie polskie
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
94578-2
FHIR
|
| Long Common Name: | Clot strength TXA2 receptor inhibited [Length fraction] in Blood by calculation |
| Short Name: | Clot strength TXA2-R inhib LenFr Bld |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
Klasyfikacja
| Class: |
PLkrzepnięcie
ENCOAG
|
| Consumer Name: | - |
| Order/Observation: | Observation |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | % |
| UCUM Units: | % |
| Version Last Changed: | 2.68 |
Definicja i opis
A calculated value representing the relative amount of clotting strength (i.e., platelet activity) that would remain in the presence of anti-platelet thromboxane A2 (TXA2)-receptor inhibiting drugs. It is the portion of clotting strength due to factors other than arachidonic acid, which activates platelets by a pathway that includes metabolism to thromboxane A2 (TXA2), which binds to the TXA2 receptor. This result is used to guide anti-platelet therapy decisions. For example, if a patient's baseline relative clotting strength due to AA activation is 25% [LOINC: 94579-0], then treating that patient with an anti-platelet TXA2 receptor inhibitor would only reduce clotting strength by 25%, leaving a predicted 75% intact.
Powiązane nazwy
Stabilność skrzepu po zahamowaniu płytkowego receptora tromboksanu A2